Latham & Watkins Advises Permira in US$1.3 Billion Acquisition of BioCatch

BioCatch (the Company), the global leader in digital fraud detection and financial crime prevention powered by behavioral biometric intelligence, has announced that Permira Growth Opportunities II, a fund advised by global private equity firm Permira, has agreed to acquire a majority position in the Company. The transaction is expected to accelerate the Company’s global expansion, advance its innovative product roadmap and support its continued overall growth. Under the terms of the agreement, the Fund will acquire a majority stake in the Company, buying out shares primarily from Bain Capital Tech Opportunities and Maverick Ventures, in a secondary transaction valuing BioCatch at a total enterprise valuation of US$1.3 billion.

Latham & Watkins LLP represents Permira in the transaction with a private equity M&A team led by Washington, D.C. partners Brian Mangino and Elizabeth More, with associate Hanks Bird. Advice was also provided on benefits and compensation matters by Washington, D.C. partner Dave Della Rocca, with associate Ashlie Lawton; on intellectual property matters by Washington, D.C. partner Morgan Brubaker, with associate Caroline Toman Lammon; on antitrust matters by Washington, D.C. partners Amanda Reeves, Katherine Rocco, and Patrick English, with associate Matthew Piehl; on compliance matters by London partner Nathan Seltzer and Washington, D.C. counsel Ruchi Gill, with associates Lauren McGuire, Elizabeth Annis, Amaryllis Bernitsa, and Megan Scott-Busenbark; and on data privacy matters by Bay Area partner Michael Rubin and London partner Fiona Maclean, with associates Calum Docherty, Jennifer Howes, and Zac Alpert.